Metastatic Esophageal Cancer research hub
3 indexed studies · 1 currently recruiting
- active not recruitingPHASE1, PHASE2
WaKING: Wnt and checKpoint INhibition in Gastric Cancer
This study is for people with advanced stomach or gullet cancer that has spread, and who've already had chemotherapy. It's testing a new combination of medicines, DKN-01 and atezolizumab, to see if they are safe and can help shrink cancer.
United Kingdom - active not recruitingPHASE2
A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors
This study looks at a new combination of experimental drugs, disitamab vedotin and tucatinib, for advanced breast or stomach cancers that have a specific marker called HER2. It aims to see how safe and effective this treatment is, and what side effects it might cause.
United States · Australia · Canada - recruitingPHASE1
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors
This study is testing a new drug called IPH5301 for advanced cancers like breast, stomach, and lung. It's a first-time-in-human study, meaning it's the very first time this drug is being given to people. Researchers want to find a safe dose, either alone or with other treatments.
France